Abstract
Autoimmune diseases (AIDs) are triggered by a multitude of factors, and vitamin D is a hormone that might be involved in their development. Vitamin D acts in target tissues through signaling by an intranuclear receptor termed vitamin D receptor (VDR). The identification of VDRs in all cells of the immune system and the discovery that dendritic cells can produce the metabolically active form of vitamin D have led to the notion that vitamin D could act as an immunomodulator. In fact, vitamin D has been shown to be actively involved in the regulation of innate and adaptive immune responses. In this sense, vitamin D has been documented to be involved in several autoimmune disorders and its deficiency has been associated with the pathogenesis and severity of multiple sclerosis, type 1 diabetes mellitus, rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus, among others. Nevertheless, low levels of vitamin D have often been reported in patients with different AIDs, although it is still unclear if this finding is a cause or consequence of the disease.Regarding vitamin D supplementation in AIDs, most of the published studies have been inconclusive. However, this fact may be linked to measuring the metabolite 25(OH)D instead of the active form calcitriol.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have